Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy

被引：0
|
作者：
Mori, K. [1 ]
Kamiyama, Y. [1 ]
Kondo, T. [1 ]
Kodama, T. [1 ]
机构：
[1] Tochigi Canc Ctr, Div Med Oncol Thorac, Utsunomiya, Tochigi, Japan
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)71444-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6616
引用
收藏
页码：393 / 393
页数：1
相关论文
共 50 条
  • [31] Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: A phase II trial
    Spiridonidis, CH
    Laufman, LR
    Carman, L
    Moore, T
    Blair, S
    Jones, J
    George, C
    Patel, T
    Roach, R
    Rupert, R
    Zangmeister, J
    Colborn, D
    Kuebler, JP
    ANNALS OF ONCOLOGY, 2001, 12 (01) : 89 - 94
  • [32] Clinical study of platinum-based chemotherapy in the treatment of elderly patients with advanced non-small cell lung cancer
    Zhang, Xiaotong
    Li, Longyun
    Lu, Bo
    CHEST, 2007, 132 (04) : 590S - 591S
  • [33] Second-line chemotherapy with gemcitabine and uracil/tegafur for relapsed or refractory non-small cell lung cancer: a phase II study
    Tanaka, H.
    Tanaka, J.
    Itoh, R.
    Kuriyama, H.
    Kagamu, H.
    Itoh, K.
    Sato, K.
    Nakata, K.
    Gejyo, F.
    Yoshizawa, H.
    EJC SUPPLEMENTS, 2007, 5 (04): : 375 - 375
  • [34] A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer
    Sculier, JP
    Lafitte, JJ
    Berghmans, T
    Thiriaux, J
    Lecomte, J
    Efremidis, A
    Ninane, V
    Paesmans, M
    Mommen, P
    Klastersky, J
    LUNG CANCER, 2000, 29 (01) : 67 - 73
  • [35] Second line treatment of non-small cell lung cancer with paclitaxel and gemcitabine
    Kakolyris, S
    Kourousis, C
    Androulakis, N
    Dimopoulos, MA
    Papadakis, E
    Tzannes, S
    Kotsakis, T
    Vardakis, N
    Merambeliotakis, N
    Kalbakis, C
    Xatzidaki, D
    Georgoulias, V
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1049 - 1049
  • [36] Single agent gemcitabine in the second-line treatment of advanced non-small cell lung cancer after treatment with taxane plus platinum regimens
    Coskun, Ugur
    Kaya, Ali Osman
    Buyukberber, Sueleyman
    Benekli, Mustafa
    Uner, Aytug
    Dikilitas, Mustafa
    Ozturk, Banu
    Yildiz, Ramazan
    Ozkan, Secil
    Yaman, Emel
    Yamac, Deniz
    MEDICAL ONCOLOGY, 2008, 25 (02) : 133 - 136
  • [37] Weekly paclitaxel as second/third line chemotherapy for advanced and metastatic non-small cell lung cancer.
    Camps, C
    Caballero, C
    Garde, J
    Juarez, A
    Blasco, A
    Berrocal, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 693S - 693S
  • [38] Second-line treatment of advanced non-small cell lung cancer with paclitaxel and gemcitabine: A preliminary report on an active regimen
    Georgoulias, V
    Kourousis, C
    Kakolyris, S
    Androulakis, N
    Dimopoulos, MA
    Papadakis, E
    Kotsakis, T
    Vardakis, N
    Kalbakis, K
    Merambeliotakis, N
    Hatzidaki, D
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : 61 - 66
  • [39] A Phase II Study of First-Line Chemotherapy with Weekly Carboplatin Plus Gemcitabine in Advanced Non-Small Cell Lung Cancer
    Mori, Kiyoshi
    Kamiyama, Yukari
    Kasai, Hisashi
    Kodama, Tetsuro
    CHEMOTHERAPY, 2012, 58 (01) : 78 - 83
  • [40] Gemcitabine as second-line treatment for advanced non-small-cell lung cancer:: A phase II trial
    Crinò, L
    Mosconi, AM
    Scagliotti, G
    Selvaggi, G
    Novello, S
    Rinaldi, M
    Della Giulia, M
    Gridelli, C
    Rossi, A
    Calandri, C
    De Marinis, F
    Noseda, M
    Tonato, M
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) : 2081 - 2085
12345